TY  - JOUR
AU  - Delgado-Valverde, Mercedes
AU  - Conejo, M del Carmen
AU  - Serrano, Lara
AU  - Fernandez-Cuenca, Felipe
AU  - Pascual, Alvaro
PY  - 2020
DO  - 10.1093/jac/dkaa117
UR  - http://hdl.handle.net/10668/15357
T2  - The Journal of antimicrobial chemotherapy
AB  - Cefiderocol is a novel siderophore cephalosporin, developed for activity against MDR Gram-negative bacilli (MDR-GNB). To assess the in vitro antibacterial activity of cefiderocol against a collection of MDR-GNB clinical isolates from hospitals in...
LA  - en
PB  - Oxford University Press
KW  - Acinetobacter baumannii
KW  - Cephalosporins
KW  - Drug Resistance, Multiple, Bacterial
KW  - Pseudomonas aeruginosa
KW  - Stenotrophomonas maltophilia
KW  - Anti-Bacterial Agents
KW  - Clone Cells
KW  - Microbial Sensitivity Tests
KW  - Spain
TI  - Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
TY  - research article
VL  - 75
ER  -